-
Exclusive: Myriad Genetics Discusses The Growing Market In Genetic Testing
Wednesday, October 26, 2016 - 10:20am | 584Read More...Myriad Genetics, Inc. (NASDAQ: MYGN) is a molecular diagnostic company engaged in the development and marketing of transformative molecular diagnostic tests. The company recently announced a new relationship with ION Solutions, a part of AmerisourceBergen Corp. (NYSE: ABC), to deliver hereditary...
-
CombiMatrix Gives Up Early Morning Gains Following Announcement Of Strategic Review
Thursday, April 21, 2016 - 12:31pm | 326Read More...CombiMatrix Corp (NASDAQ: CBMX), a molecular diagnostics company, announced on Thursday it has begun to explore strategic alternatives, including potential M&A activity and business development opportunities. The company noted its strategic review process is intended to enhance shareholder...
-
Trovagene Gains 3% On Favorable Mention In Medical Journal
Friday, April 15, 2016 - 2:02pm | 300Read More...Shares of TrovaGene Inc (NASDAQ: TROV), a molecular diagnostic company, gained more than 2 percent on Friday after the company announced that it was favorably mentioned in a medical journal. TrovaGene said a patient case report feature use of its Precision Cancer Monitoring technology was...
